Gene Product Expression Technology
by Cardinal Health
GPEx, Cardinal Health’s proprietary Gene Product Expression technology, is used to construct stable, high-yielding mammalian cell lines with unmatched speed and efficiency. GPEx technology uses a retrovector technology—a pseudotyped, replication defective, high-titer vector that ensures the stable transduction of targeted cells, approaching 100% efficiency.
| Published: | 2004 |
| Format: | |
| Length: | 2 pages |
| Type: | Product Collateral |
| Language: | English |
.
SPONSORED REPORTS
